Polycystin-1/PKD1 Antibody (PKS161f/B7) - BSA Free

Novus Biologicals | Catalog # NBP2-50247

Novus Biologicals
100% Guarantee

Key Product Details

Species Reactivity

Human

Applications

Immunohistochemistry, Western Blot

Label

Unconjugated

Antibody Source

Monoclonal Mouse IgG1 kappa Clone # PKS161f/B7

Format

BSA Free
View all Polycystin-1/PKD1 Primary Antibodies »

Product Specifications

Immunogen

Recombinant protein (233 aa)

Clonality

Monoclonal

Host

Mouse

Isotype

IgG1 kappa

Scientific Data Images for Polycystin-1/PKD1 Antibody (PKS161f/B7) - BSA Free

Polycystin-1/PKD1 Antibody (PKS161f/B7) - BSA Free

Western Blot: Polycystin-1/PKD1 Antibody (PKS161f/B7) - BSA Free [NBP2-50247] -

The effects of downregulation and overexpression of PKD-1 on the phenotypes of aortic VSMCs (n = 6 for each group). (A) PKD-1 knockdown inhibited the expression of (A,B1) PC-1 (p < 0.0001, p < 0.0001), (A,B2) calponin (p = 0.0001, p = 0.0008) and (A,B3) SM22 alpha (p = 0.0053, p = 0.0194) as well as elevated the expression of (A,B4) OPN (p < 0.0001, p = 0.0037), (A,B5) MYH10 (p < 0.0001, p = 0.0001), (A,B7) MMP-2 (p < 0.0001, p = 0.0003) Rapamycin didn’t affect the expression of (A,B1) PC-1 (p < 0.0001, p < 0.0001) in sh-PKD-1 VSMCs but elevated the expression of (A,B2) calciponin (p = 0.0026, p = 0.0038) and (A,B3) SM22 alpha (p = 0.0352, p = 0.034) and downregulated the expression of (A,B4) OPN (p = 0.0009, p = 0.0101), (A,B5) MYH10 (p = 0.0002, p = 0.0105), (A,B7) MMP2 (p < 0.0001, p = 0.0031). (A,B6) Showed the protein expression of MMP-1 among three groups. Treatment of sg-PKD-1 enhanced the expression of (C,D1) PC-1 (p < 0.0001, p < 0.0001), (C,D2) calciponin (p = 0.0054, p = 0.0004) and (C,D3) SM22 alpha (p = 0.0005, p = 0.0003), but inhibited the expression of (C,D4) OPN (p = 0.0125, p = 0.0002), (C,D5) MYH10 (p = 0.0078, p = 0.0002), (C,D7) MMP2 (p < 0.0001, p = 0.0009). (C,D6) Showed the protein expression of MMP-1between normal and sg-PKD-1 VSMCs. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001 (compared with normal VSMCs); ##p < 0.01, ###p < 0.001 (compared with TAD VSMCs). #Means the comparison between sh-PKD1 and sh-PKD1 + Rapa VSMCs. p < 0.05. Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/33071810), licensed under a CC-BY license. Not internally tested by Novus Biologicals.
Polycystin-1/PKD1 Antibody (PKS161f/B7) - BSA Free

Western Blot: Polycystin-1/PKD1 Antibody (PKS161f/B7) - BSA Free [NBP2-50247] -

The effects of downregulation and overexpression of PKD-1 on the phenotypes of aortic VSMCs (n = 6 for each group). (A) PKD-1 knockdown inhibited the expression of (A,B1) PC-1 (p < 0.0001, p < 0.0001), (A,B2) calponin (p = 0.0001, p = 0.0008) and (A,B3) SM22 alpha (p = 0.0053, p = 0.0194) as well as elevated the expression of (A,B4) OPN (p < 0.0001, p = 0.0037), (A,B5) MYH10 (p < 0.0001, p = 0.0001), (A,B7) MMP-2 (p < 0.0001, p = 0.0003) Rapamycin didn’t affect the expression of (A,B1) PC-1 (p < 0.0001, p < 0.0001) in sh-PKD-1 VSMCs but elevated the expression of (A,B2) calciponin (p = 0.0026, p = 0.0038) and (A,B3) SM22 alpha (p = 0.0352, p = 0.034) and downregulated the expression of (A,B4) OPN (p = 0.0009, p = 0.0101), (A,B5) MYH10 (p = 0.0002, p = 0.0105), (A,B7) MMP2 (p < 0.0001, p = 0.0031). (A,B6) Showed the protein expression of MMP-1 among three groups. Treatment of sg-PKD-1 enhanced the expression of (C,D1) PC-1 (p < 0.0001, p < 0.0001), (C,D2) calciponin (p = 0.0054, p = 0.0004) and (C,D3) SM22 alpha (p = 0.0005, p = 0.0003), but inhibited the expression of (C,D4) OPN (p = 0.0125, p = 0.0002), (C,D5) MYH10 (p = 0.0078, p = 0.0002), (C,D7) MMP2 (p < 0.0001, p = 0.0009). (C,D6) Showed the protein expression of MMP-1between normal and sg-PKD-1 VSMCs. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001 (compared with normal VSMCs); ##p < 0.01, ###p < 0.001 (compared with TAD VSMCs). #Means the comparison between sh-PKD1 and sh-PKD1 + Rapa VSMCs. p < 0.05. Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/33071810), licensed under a CC-BY license. Not internally tested by Novus Biologicals.

Applications for Polycystin-1/PKD1 Antibody (PKS161f/B7) - BSA Free

Application
Recommended Usage

Immunohistochemistry

1:10 - 1:500

Western Blot

1:100 - 1:2000

Formulation, Preparation, and Storage

Purification

Protein A purified

Formulation

PBS

Format

BSA Free

Preservative

0.02% Sodium Azide

Concentration

1 mg/ml

Shipping

The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.

Stability & Storage

Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.

Background: Polycystin-1/PKD1

Polycystin-1 (also PKD1) is a 500-550 kDa member of the polycystin family of proteins. It is expressed in renal tubule primary cilia, and the membrane region that forms adherens junctions. Polycystin-1 binds to polycystin-2, promoting its insertion into the cell membrane, and regulating its calcium channel activity. In conjunction with polycystin-2, it detects fluid flow and converts this information into calcium signals. It also exists in the ER, where it negatively modulates polycystin-2 mediated calcium release. Mature human polycystin-1 is a 4280 amino acid (aa), 11 transmembrane glycoprotein. Its N-terminal extracellular region (aa 24-3074) is highly modular, and contains a C-type lecin domain, multiple Leu-rich repeats and PKD domains, one GPS region and a PLAT, REJ, WSC and LDLR domain. The cytoplasmic C-terminus (aa 4107-4303) contains a polycystin-2 coiled-coil interaction domain (aa 4220-4251). A percentage of polycystin-1 undergoes autoproteolysis after Leu3048, generating a presumed N-terminal fragment of ~ 350-400 kDa, and a membrane-bound C-terminal fragment of 150 kDa. Over aa 4141-4303, human polycystin-1 shares 71% aa identity with mouse polycystin-1.

Alternate Names

Pc-1, PKD1, Polycystin1, TRPP1

Gene Symbol

PKD1

Additional Polycystin-1/PKD1 Products

Product Documents for Polycystin-1/PKD1 Antibody (PKS161f/B7) - BSA Free

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot or batch number in the search box below.

Download SDS

Product Specific Notices for Polycystin-1/PKD1 Antibody (PKS161f/B7) - BSA Free

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

Citations for Polycystin-1/PKD1 Antibody (PKS161f/B7) - BSA Free

Customer Reviews for Polycystin-1/PKD1 Antibody (PKS161f/B7) - BSA Free

There are currently no reviews for this product. Be the first to review Polycystin-1/PKD1 Antibody (PKS161f/B7) - BSA Free and earn rewards!

Have you used Polycystin-1/PKD1 Antibody (PKS161f/B7) - BSA Free?

Submit a review and receive an Amazon gift card!

$25/€18/£15/$25CAN/¥2500 Yen for a review with an image

$10/€7/£6/$10CAN/¥1110 Yen for a review without an image

Submit a review
Amazon Gift Card

Protocols

Find general support by application which include: protocols, troubleshooting, illustrated assays, videos and webinars.

FAQs

No product specific FAQs exist for this product.

View all FAQs for Antibodies